The EU Commission increases merger control enforcement in the pharmaceutical sector

Veering off the well-trodden path? European Merger Control and the Pharmaceutical Indutry* We have recently celebrated the 25th anniversary of the EU Merger Regulation, which came into force on 21 September 1990. Since that date, we have seen an exponential growth in merger control notifications at the European level – at least up until the financial crisis that began in 2008. The good news is that, to the end of September 2015, there have been 247 notifications this year. We appear to be on track for approximately 330 notification in total for 2015. This almost reaches the level of notifications in 2008 (348) – albeit somewhat off the all time high of 2007 (402). But what does this mean to the pharmaceutical industry? It has been at the vanguard of the resurgence in M&A since

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • Baker McKenzie (Brussels)

Quotation

Gavin Bushell, The EU Commission increases merger control enforcement in the pharmaceutical sector, 29 October 2015, e-Competitions Bulletin October 2015, Art. N° 76407

Visites 818

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues